NTBC ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
241	Hypertyrosinemia type I	2

241. Hypertyrosinemia type I

---

Clinical trials : 14 /  Drugs : 7 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathways : 5

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00004443 (ClinicalTrials.gov)	October 1998	18/10/1999	Study of NTBC for Tyrosinemia I		Tyrosinemia I	Drug: NTBC	University of Washington	NULL	Completed	N/A	17 Years	Both	20	N/A	United States;Canada
2	NCT00004333 (ClinicalTrials.gov)	November 1994	18/10/1999	Phase II Study of the Enzyme Inhibitor NTBC for Tyrosinemia Type I		Tyrosinemia, Type I	Drug: NTBC	National Center for Research Resources (NCRR)	University of Michigan	Completed	N/A	N/A	Both		Phase 2	NULL